.Basilea Pharmaceutica's work establishing brand new antifungals has actually gotten a considerable ...
.Having actually gathered up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscle...
.After pushing the decision meeting for Applied Therapies' metabolic condition medication govorestat...
.Novo Nordisk is actually proceeding its own press right into genetic medications, accepting pay Nan...
.Innovent Biologics has actually made the case that its own gate inhibitor-cytokine fusion healthy p...
.A stage 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (A...
.5 months after Rakovina Therapies pivoted towards artificial intelligence, the cancer-focused biote...
.Ascendis Pharma has actually emerged as a possible risk to BioMarin's Voxzogo, stating stage 3 grow...
.Though Alkeus Pharmaceuticals' dental eye disease resource stopped working to dramatically lessen g...
.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to mis...
.Immune gate inhibitors are actually the superheroes of cancer cells therapy. Medicines like Bristol...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, firings...
.Regeneron is actually back with long-lasting consequence for its LAG-3 inhibitor and also PD-1 prev...
.AstraZeneca has actually shared a very early consider the performance of its own internal antibody-...
.After revealing a phase 3 launch based upon good midstage outcomes, iTeos as well as GSK are actual...
.The FDA needs to be much more open and also collaborative to discharge a surge in commendations of ...
.It's an unusually active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Rehabs ...
.Atea Pharmaceuticals' antiviral has actually stopped working an additional COVID-19 trial, however ...
.Neurocrine Biosciences' mental illness plan pivot has actually failed. The biotech was actually not...
.Sanofi has made a late entry to the radioligand gathering, paying 100 million euros ($ 110 million)...